US Broker Ratings

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating 22.82% Potential Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might want to turn their attention to Koninklijke Philips N.V. (NYSE: PHG). This Dutch-based giant, with a market capitalization of $26.13 billion, is..

Medtronic plc (MDT) Stock Analysis: Exploring a 29.62% Potential Upside in the Healthcare Sector

Medtronic plc (NYSE: MDT), a giant in the healthcare industry, continues to be a focal point for investors seeking stability and growth in the medical devices sector. With a market..

Haleon plc (HLN) Stock Analysis: Exploring a 23% Upside Amidst Steady Healthcare Demand

Haleon plc (HLN), a formidable player in the healthcare sector, is catching the eyes of investors with its promising growth potential. As a specialist in consumer healthcare products, Haleon has..

Centene Corporation (CNC) Stock Analysis: A 3.95% Potential Upside Amidst Healthcare Growth

Centene Corporation (NYSE: CNC) is a prominent player in the healthcare plans sector, holding a significant presence in the United States market. With a market capitalization of $20.57 billion, the..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 28.6% Upside Potential in the Animal Health Sector

For investors eyeing opportunities within the healthcare sector, Zoetis Inc. (NYSE: ZTS) presents an intriguing proposition. With a market capitalization of $49.33 billion, Zoetis stands as a formidable player in..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential with a 106.10% Return on Equity

As one of the leading titans in the global healthcare sector, Amgen Inc. (NASDAQ: AMGN) has consistently demonstrated its prowess in developing and delivering innovative human therapeutics. With a market..

Gilead Sciences (GILD) Stock Analysis: Evaluating a 21.44% Potential Upside in the Biopharma Giant

Gilead Sciences, Inc. (NASDAQ: GILD) remains a heavyweight in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $161.85 billion, this biopharmaceutical giant continues..

UnitedHealth Group (UNH) Stock Analysis: Discover the 8.78% Potential Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, is garnering significant attention from investors, driven by its robust market position and promising analyst ratings. As a leading..

Merck & Co., Inc. (MRK) Stock Analysis: A 15.94% Potential Upside with Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK), a cornerstone in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic partnerships. With a market capitalization of $276.38..

Atrium Therapeutics, Inc. (RNA): Investor Outlook Highlights 73.49% Upside Potential

Atrium Therapeutics, Inc. (NASDAQ: RNA), a biopharmaceutical innovator specializing in RNA therapeutics for cardiomyopathies, is garnering attention for its promising pipeline and significant upside potential. With a market capitalization of..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Unveiling a 55.60% Potential Upside

For investors keen on the healthcare sector, particularly the medical devices industry, iRhythm Holdings, Inc. (NASDAQ: IRTC) presents an intriguing investment opportunity. With a market capitalization of $4.05 billion, this..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the Future of RNA-Targeted Therapeutics with Promising Forward P/E

For investors keen on the biotechnology sector, Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a company worth watching due to its cutting-edge research in RNA-targeted therapeutics and gene therapies. Although navigating..

Nuvalent, Inc. (NUVL) Stock Analysis: Unveiling a 32% Potential Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising pipeline of cancer therapies and a striking analyst consensus that forecasts a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 26% Potential Upside in the Biotech Sector

For investors with a keen eye on the healthcare sector, TG Therapeutics, Inc. (NASDAQ: TGTX) offers an intriguing opportunity. This biopharmaceutical company, with its focus on innovative treatments for B-cell..

Guardant Health, Inc. (GH) Stock Analysis: Exploring a Potential 42% Upside in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the precision oncology sector, is capturing investor attention with a potential upside of 42.06%, according to analyst ratings. As a company..

Rhythm Pharmaceuticals (RYTM): Analyst Consensus Suggests 55% Upside Potential for Investors

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of the biotechnology sector with a targeted focus on rare neuroendocrine diseases. With a market capitalization of $6.06 billion, this Boston-based..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 101% Potential Upside in Biotech Innovation

Telix Pharmaceuticals Limited (TLX), a prominent player in the biotechnology sector, is making waves with its innovative approach to radiopharmaceuticals. With a market cap of $3.64 billion, this Australia-based company..

Legend Biotech Corporation (LEGN): Analyst Consensus Reveals 170% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is a notable player in the biotechnology sector, positioning itself at the forefront of innovative cancer treatments. Headquartered in Somerset, New Jersey, this biopharmaceutical company..

Bausch + Lomb Corporation (BLCO)

⚠️ No article content returned.

..

Roivant Sciences Ltd. (ROIV)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds